[Bacteremia caused by Campylobacter jejuni resistant to nalidixic acid and fluoroquinolones].
Gómez
J L
JL
Alos
J I
JI
Amor
E
E
Cogollos
R
R
Pérez
A
A
D000328:Adult; D016470:Bacteremia / Q000150:complications / Q000382:microbiology*; D002169:Campylobacter Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D016123:Campylobacter jejuni / Q000187:drug effects / Q000302:isolation & purification*; D002512:Cephalothin / Q000494:pharmacology* / Q000627:therapeutic use; D003967:Diarrhea / Q000150:complications; D004352:Drug Resistance, Microbial; D006679:HIV Seropositivity / Q000150:complications; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D009268:Nalidixic Acid / Q000494:pharmacology* / Q000627:therapeutic use
D009268:Nalidixic Acid; D002512:Cephalothin
Bacteriemia por Campylobacter jejuni resistente a ácido nalidíxico y fluoroquinolonas.